Pr Jean Trédaniel
- Spécialité
- Oncologue médical, expert poumon
- Hôpital
- Groupe hospitalier Paris Saint Joseph (Paris)
- Derniers articles
-
- Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020. (1 juil. 2025)
- Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study). (4 déc. 2022)
- Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study. (1 nov. 2022)
- Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies. (29 août 2022)
- Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study. (11 août 2022)